Each year, The Max Foundation channels millions of doses of cancer medicines to thousands of patients around the globe, some of whom have accessed treatment through our programs for more than a decade. With such a large, enduring, and diverse patient population, it’s important that we play our part in contributing to the body of knowledge regarding drug side effects.
Knowing whether a particular drug will cause a severe reaction in someone with heart disease, for instance, is critical information when making treatment decisions. And cancer treatment often involves a series of difficult decisions. No one can guarantee that your specific cancer will respond to a specific therapy. Nor can anyone guarantee that the list of scary side effects won’t become your new normal.
That’s why reporting these side effects is so important. And that’s why we’ve developed systems to ensure adverse event reports are shared promptly with local health authorities through prescribers, and with drug manufacturers alike.
In addition to benefitting the medical and patient communities at large, our reports also fill an important gap in countries where national systems for collecting them are less developed. We can support prescribers in these countries by guaranteeing reports make their way into global repositories of information regarding the safety of cancer drugs.
You can learn more about the systems we’ve pioneered, from committing staff resources to building a web-based reporting form, in our publication in the journal Globalization and Health, “A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience”.
All of us who work in the field of medical donations have the potential to contribute directly to patient safety. If you’re interested in learning more about our efforts, or learning how your organization can do more with reporting, I hope you’ll connect with us.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Year after year I dread this day, March 9th, the day cancer took Max from us. No matter how many years pass, how excited I might be about our progress, our goals and vision for the future, as the day approaches, I feel a dark cloud settling in. Suddenly I am back to 1991 and….
Bunthan Kahn was diagnosed with chronic myeloid leukemia (CML) in 2017. He’s a tour guide, a husband, a young father, and an avid learner. From traveling far to meet with specialized physicians, to seeking treatment in his country, his journey toward finding hope took perseverance.
The journey from experiencing the first symptoms of chronic myeloid leukemia (CML) to finding an effective treatment can be long, difficult, and painful, especially in low- and middle-income countries. That was the case for Chamu from Harare, Zimbabwe. It took him more than a year to get a diagnosis, but he kept fighting and is….
